Metabolic engineering of Escherichia coli for improving l-3,4-dihydroxyphenylalanine (l-DOPA) synthesis from glucose
- 1.6k Downloads
l-3,4-dihydroxyphenylalanine (l-DOPA) is an aromatic compound employed for the treatment of Parkinson's disease. Metabolic engineering was applied to generate Escherichia coli strains for the production of l-DOPA from glucose by modifying the phosphoenolpyruvate:sugar phosphotransferase system (PTS) and aromatic biosynthetic pathways. Carbon flow was directed to the biosynthesis of l-tyrosine (l-Tyr), an l-DOPA precursor, by transforming strains with compatible plasmids carrying genes encoding a feedback-inhibition resistant version of 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase, transketolase, the chorismate mutase domain from chorismate mutase-prephenate dehydratase from E. coli and cyclohexadienyl dehydrogenase from Zymomonas mobilis. The effects on l-Tyr production of PTS inactivation (PTS− gluc+ phenotype), as well as inactivation of the regulatory protein TyrR, were evaluated. PTS inactivation caused a threefold increase in the specific rate of l-Tyr production (q l-Tyr), whereas inactivation of TyrR caused 1.7- and 1.9-fold increases in q l-Tyr in the PTS+ and the PTS− gluc+ strains, respectively. An 8.6-fold increase in l-Tyr yield from glucose was observed in the PTS− gluc+ tyrR − strain. Expression of hpaBC genes encoding the enzyme 4-hydroxyphenylacetate 3-hydroxylase from E. coli W in the strains modified for l-Tyr production caused the synthesis of l-DOPA. One of such strains, having the PTS− gluc+ tyrR − phenotype, displayed the best production parameters in minimal medium, with a specific rate of l-DOPA production of 13.6 mg/g/h, l-DOPA yield from glucose of 51.7 mg/g and a final l-DOPA titer of 320 mg/l. In a batch fermentor culture in rich medium this strain produced 1.51 g/l of l-DOPA in 50 h.
KeywordsE. coli Aromatics l-tyrosine l-DOPA Phosphotransferase system TyrR transcriptional dual regulator
This work was supported by CONACyT grants 83039 and 126793. AJM was supported by a fellowship from CONACyT. We thank Luz María Martínez, Mercedes Enzaldo, Juan Manuel Hurtado, Mario Trejo and Martín Patiño for technical assistance.
- 4.Chavez-Bejar MI, Lara AR, Lopez H, Hernandez-Chavez G, Martinez A, Ramirez OT, Bolivar F, Gosset G (2008) Metabolic engineering of Escherichia coli for l-tyrosine production by the expression of genes coding for the chorismate mutase domain of the native chorismate mutase-prephenate dehydratase and a cyclohexadienyl dehydrogenase from Zymomonas mobilis. Appl Environ Microbiol 74:3284–3290PubMedCrossRefGoogle Scholar
- 6.De Anda R, Lara AR, Hernandez V, Hernandez-Montalvo V, Gosset G, Bolıvar F, Ramırez OT (2006) Replacement of the glucose phosphotransferase transport system by galactose permease reduces acetate accumulation and improves process performance of Escherichia coli for recombinant protein production without impairment of growth rate. Metab Eng 8:281–290PubMedCrossRefGoogle Scholar
- 14.Kramer M, Kremer-Muschen S, Wubbolts MG (2006) Process for the preparation of l-3, 4-dihydroxyphenylalanine by aerobic fermentation of a microorganism. US Patent 2006/0141587A1Google Scholar
- 17.Lee SG, Hong SP, Sung MH (1999) Development of an enzymatic system for the production of dopamine from catechol, pyruvate and ammonia. Enzyme Microb Technol 25:268–302Google Scholar
- 20.Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring, NY, p 68Google Scholar
- 26.Reinhold DF, Utne T, Abramson NL (1987) Process for L-dopa. US patent 4716246Google Scholar
- 28.Takai A, Nishi R, Joe Y, Ito H (2005) l-Tyrosine producing bacterium and a method for producing l-tyrosine. US Patent application no. 2005/0277179A1Google Scholar